The World Health Organisation (WHO) has revealed that Nigeria has expressed interest to be part of the global solidarity drug trial to combat COVID-19. The WHO launched solidarity drug trials for these specific drugs hydroxychloroquine, chloroquine phosphate, and remdesivir in April, Daily Trust reports.
Speaking at the joint national briefing of the presidential task force (PTF) on COVID-19, Fiona Braka, the officer in charge, WHO Nigeria, said efforts are underway to start the process in the country. She said more than 100 countries have joined the solidarity clinical trial, which was launched by WHO and some partners, to help find an effective treatment for COVID-19.
She said over 1,200 patients have been randomized from the first five countries to evaluate the “safety and efficacy of drug combinations”. Braka also said a total of 89 vaccines are being developed globally, including seven in clinical evaluation and several therapeutics in clinical trials.
220 new cases of #COVID19;
— NCDC (@NCDCgov) May 2, 2020
62-Lagos
52-FCT
31-Kaduna
13-Sokoto
10-Kebbi
9-Yobe
6-Borno
5-Edo
5-Bauchi
4-Gombe
4-Enugu
4-Oyo
3-Zamfara
2-Nasarawa
2-Osun
2-Ebonyi
2-Kwara
2-Kano
2-Plateau
2388 confirmed cases of #COVID19 in Nigeria
Discharged: 385
Deaths: 85 pic.twitter.com/06ZsNqpWU8
| Posted: at | |
vicky987
SweetDaddy1
Slimchery
EMMYBOSS
TRENDING GISTS 
Don't Choose to be Lonely Because of People - Judy Austin Dishes Tips on Fighting For 'Love'
Outcry As Lagos Govt Begins Demolition on Parts of Arowojobe, Mende Estate (Video)
Actress Genevieve Nnaji Appreciates Her Fans, Shares Special Moment From Fer 45th Birthday
How 40yr Old Man Lured 13yr Old Girl With N200 to His House & Held Her From January to March
Liverpool v Tottenham: English Premier League Match,Team News,Goal Scorers and Stats